AZD-3199

• Description :

  AZD-3199 is an ultra-long-acting beta2 agonist with potential activity against asthma and chronic obstructive pulmonary disease[1].

• UNSPSC :

  12352005

• Target :

  Endogenous Metabolite

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/azd-3199.html

• Smiles :

  O=C1SC2=C(N1)C(O)=CC=C2CCNCCN(CCN(CC)CC)C(CCOCCC3=CC=CC4=C3C=CC=C4)=O

• Molecular Formula :

  C32H42N4O4S

• Molecular Weight :

  578.77

• References & Citations :

  [1]Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA)

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 2

• CAS Number :

  [925243-19-2]